Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

An Introduction
To Arcinova

Accelerate your drug development with Arcinova, an agile, experienced CDMO partner. Our passion is to help you deliver your life changing medicines to market with speed and efficiency.

Your project, our passion. With dedicated project management and nearly 40 years of successful delivery from our 160,000ft2 (15,000m2)  single site in the UK, award-winning Arcinova is your fully integrated partner of choice from candidate to phase 2. Strong relationships with our discovery and clinical partners ensures fewer hand-over headaches on the journey of your molecule, to maximise your chances of success.

READ MORE

Integrated Services,
Under One Roof

Whether you require drug substance process route selection, bioanalysis, synthesis, scale up of APIs/HPAPIs or final drug product manufacture, we have the expertise on-site to deliver quality solutions.

What Customers Said

Latest News

Arcinova announces major investment in Alnwick site with the installation of the R1000 capsule fill machine from 3P Innovation

Read More

Arcinova Increases LC-MS/MS Capability with Addition of Sciex 6600 Triple TOF Mass Spectrometer

Read More

New case study released: Bringing the Manufacturing Process to Life Adapting from Terminal Sterilisation to Aseptic Manufacture

Read More

Accelerated Formulation Case Study Released

Read More